Biochemical Reagent
-
BA2280 GRL-0496Summary: GRL-0496 is a potent chloropyridine ester-derived inhibitor. - BA2281 BamlanivimabSummary: Bamlanivimab (Anti-HumanSARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to receive Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) in November 2020.
- BA2282 YH-53Summary: YH-53 is a potent inhibitor.
- BA2283 MM3122Summary: MM3122 is a selective inhibitor of type II transmembrane serine proteases.
- BA2284 BofutrelvirSummary: Bofutrelvir (FB2001) is a major protease inhibitor of SARS-CoV-2.
- BA2285 ArbemnifosbuvirSummary: Arbemnifosbuvir is a nucleovirus RdRp-associated nucleotide group transferase (NiRAN) nonstructural protein 12 (nsp12) interfering drug.
- BA2287 4-O-MethylbavachalconeSummary: 4'-O-Methylbavachalcone is a chalcone isolated from psoralen.
- BA2288 WU-04Summary: WU-04 is a non-covalent inhibitor of SARS-CoV-2 targeting the 3CLpro protein.
- BA2289 SSAA09E2Summary: SSAA09E2 is a novel replication inhibitor.
- BA2290 TKB245Summary: TKB245 is a potent inhibitor.